The paper deals with the identification of occupational injury among workers in
22 alkylated polycyclic aromatic hydrocarbons (alk-PAHs) were characterized in ambient air individually for the first time in urban and semi-urban locations in Toronto, Canada. Five unsubstituted PAHs were included for comparison. Results from the measurements were used to estimate benzo[a]pyrene equivalent toxicity (BaPeq) of individual compounds in order to investigate the significance of a single compound in contributing to the overall toxic equivalency (TEQ) of air mixtures. To determine which compounds merit further investigation, BaPeq values of individual compounds were compared to the measured BaP toxicity. Our results showed that both unsubstituted and alkylated PAHs were more abundant in the urban area (38 and 30%, respectively). Benzo[a]pyrene levels at the urban location exceeded Ontario’s 24 h guideline (40% of the events), and on average, it was 5 times higher than that at the semi-urban area. Gas-phase two- and three-ring compounds contributed up to 39% (urban) and 76% (semi-urban) of the TEQ of all compounds analyzed. Some alk-PAHs such as 7,12-dimethylbenzo[a]anthracene had a huge impact on the toxicity of urban air, and its BaPeq was on average 8 times higher than that of BaP. We emphasize that the toxic impact of alkylated and gaseous PAHs, which is not routinely included in many air monitoring programs, is significant and should not be neglected.
The global crisis of the present era, the COVID-19 pandemic, has changed given new normal ways in many of the sectors. The present review highlights the impact, problems, and challenges faced by major areas of the health care sector due to pandemics and also addresses some of the aspects of upcoming approaches. The healthcare sector is the one sector that is on-demand since this COVID-19 pandemic raised. During the initial period, there was disruption of various services provided by the health care sector due to supply chain management issues and reduction in demand by consumers, quarantine, and lockdown period. The healthcare workers also confronted a huge challenge due to the increased number of cases and shortage of amenities and safety measures. This significantly affected even COVID-19 patients and the general public suffering from other diseases. To fight this issue, research and development (RandD) in pharmaceutical industries with great efforts to explore molecules and save many lives. Gradually innovative ways to strengthen and combat pandemics started emerging. Numeral ways and rules were adopted to prevent, diagnose and cure the disease. Artificial intelligence technology has emerged as one of the boons to address many of the unresolved or time-consuming mysteries. All the divisions of health care sectors have started working more efficiently with adopted new strategies to face future challenges.
Identification of a new drug molecule to a new target, specifically viral, bacterial, and fungal infection, is the prime focus of time immortal. The tridiagonal practice of drug discovery for emerging viral infection turned out to be a new venture to combat the morbidly and mortality of recent pandemics due to viral, bacterial, fungal, infection and infestation, the emerging number of viral infections day by day, the targeted therapy with the gap in assessment lead to reprofiling or repositioning available FDA-approved formulation give promising drug candidate for various infection specifically the current scenario of antiviral drug-reprofiling through drug designing approach, the emergence of resistance to existing antiviral drugs and re-emerging viral infections are the greatest challenges in antiviral drug discovery. The reprofiling approach is a worthy strategy to get the potent antiviral in brief span of time to overcome the challenges in antiviral therapy. The present chapter will be another representing the most promising results of reprofiling (Repositioning or repurposing) approach in the treatment of various infectious diseases.
Mohammed Asif Iqbal, Manager/ Principal consultant, Pwc India Asif lost total eye sight at the age of 16 years old and is first blind commerce graduate from St. Xavier's college, Calcutta. He received my primary, secondary and partial college education from USA. Asif has been instrumental in creating reservation quota for disabled across IIMs, IITs and all government Universities in india. He is also the first blind MBA(HR) from symbiosis (SCMHRD, Pune). Asif if the proud recipeient of National award, State role model award, United nation &Icongo award, NIVH excellence award, rotary community change champion award, etc. He is currently serving as President, Welfare Society of the Blind , and as member of Board of National NHRDN Kolkata chapter. He is also member of High level advisory committee of universal access set up by Department of IT & electronics, government of India. Asif has also designed & implemented social inclusion strategy for aadhar enrolllment under leadership and guidance of Nandan Nilekan and RS Sharma.
The background of green chemistry represents the dramatic module of a new millennium, the substantiable chemical process steam for evaluation in designing phase to incorporate the principles of GC (Green Chemistry) in 1990s. there has been a tremendous success in developing a new product and process which are more compatible with biological, zoological and botanical perspective to illuminate the sustainability goal, this chapter represents the simplified way to lookout different approach adopted in GC-research, the methodology enhance the chemical process economics, concomitant which deduct the environmental burden. This review merely focusing on eco-friendly protocol which replace the traditional method of synthesis followed in chemistry to synthesize lifesaving drugs, with prevention outgoing waste from industries. GC and chemical engineering or green engineering (GE) should produce eco-friendly chemical process for drug design which likely to be spread rapidly in next few decades. This chapter explains in-depth and compact with detailed glimpse of environment friendly-protocol and principle bridging continent and scientific discipline to create new solution.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.